Hemoadsorption in Heart Failure Requiring Mechanical Circulatory Support—A Systematic Review and Meta-Analysis

Hemoadsorption in Heart Failure Requiring Mechanical Circulatory Support—A Systematic Review and Meta-Analysis

Background: Left ventricular assist devices (LVAD) and extracorporeal membrane oxygenation (ECMO) are well established therapies in heart failure (HF) management. Their use is generally associated with a sudden increase in inflammatory mediators, which are often already elevated in patients with HF...

Full description

Bibliographic Details
Main Authors:	Sebastian Freiburger, Tulio Caldonazo, Panagiotis Tasoudis, Gloria Färber, Paul Christian Schulze, Marcus Franz, Torsten Doenst, Hristo Kirov, Mahmoud Diab
Format:	Article
Language:	English
Published:	IMR Press 2023-05-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	cytosorb® extracorporeal membrane oxygenation left ventricular assist device heart failure
Online Access:	https://www.imrpress.com/journal/RCM/24/5/10.31083/j.rcm2405137

Similar Items

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study
by: Willem Pieter Brouwer, et al.
Published: (2019-09-01)

Impact of hemoadsorption with CytoSorb® on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis
by: Golschan Asgarpur, et al.
Published: (2025-01-01)

Hemoadsorption Using CytoSorb<sup>®</sup> in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis
by: Cristina Rao, et al.
Published: (2023-08-01)

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?
by: Pedja Kovacevic, et al.
Published: (2023-10-01)

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report
by: Vittorio Dalmastri, et al.
Published: (2023-07-01)

Impact of Continuous Kidney Replacement Therapy and Hemoadsorption with CytoSorb on Antimicrobial Drug Removal in Critically Ill Children with Septic Shock: A Single-Center Prospective Study on a Pediatric Cohort
by: Gabriella Bottari, et al.
Published: (2023-08-01)

Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease
by: Hristo Kirov, et al.
Published: (2023-12-01)

Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force
by: Lui Forni, et al.
Published: (2024-07-01)

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
by: Christopher Rugg, et al.
Published: (2020-11-01)

Hemoadsorption by CytoSorb in septic patients: a case series
by: Klaus Kogelmann, et al.
Published: (2017-03-01)

The role of hemoadsorption in cardiac surgery – a systematic review
by: Marijana Matejic-Spasic, et al.
Published: (2024-05-01)

Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting
by: Helmut Mair, et al.
Published: (2024-04-01)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Marianne Alarie, et al.
Published: (2022-07-01)

Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review
by: Vitor Mendes, et al.
Published: (2024-04-01)

Conservative Versus Surgical Therapy in Patients With Infective Endocarditis and Surgical Indication—Meta‐Analysis of Reconstructed Time‐to‐Event Data
by: Tulio Caldonazo, et al.
Published: (2024-04-01)

Paediatric patient with dengue fever and associated multi-organ dysfunction syndrome (MODS) receiving hemoadsorption using Cytosorb® – A case report on clinical experience
by: S. Kumar, et al.
Published: (2020-05-01)

CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
by: Anouk Frering, MD, et al.
Published: (2025-02-01)

Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry
by: Michael Schmoeckel, et al.
Published: (2025-01-01)

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
by: Aron Jansen, et al.
Published: (2023-03-01)

Does adjunctive hemoadsorption provide benefit in the management of ischemia–reperfusion syndrome following near-drowning? A case report
by: Pedja Kovacevic, et al.
Published: (2024-04-01)

Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption
by: Juan Carlos Ruiz-Rodríguez, et al.
Published: (2022-04-01)

Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)—A case report
by: Erich Moresco, et al.
Published: (2022-01-01)

The Eﬀect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications
by: A. S. Rybalko, et al.
Published: (2024-09-01)

Extracorporeal cytokine adsorption reduces systemic cytokine storm and improves graft function in lung transplantationCentral MessagePerspective
by: Jonas Peter Ehrsam, MD, et al.
Published: (2023-09-01)

Comparing percutaneous coronary intervention and coronary artery bypass grafting for left main stenosis on the basis of current regional registry evidenceCentral MessagePerspective
by: Hristo Kirov, MD, et al.
Published: (2024-12-01)

Intraoperative immunomodulation during left heart bypass in open thoracoabdominal aortic aneurysm repair
by: Federico Pascucci, MD, et al.
Published: (2023-09-01)

Immunomodulation by Hemoadsorption—Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study
by: Janina Praxenthaler, et al.
Published: (2022-09-01)

Association of liver dysfunction with outcomes after percutaneous coronary intervention – a systematic review and meta-analysis
by: Tulio Caldonazo, et al.
Published: (2024-10-01)

Coronavirus disease 2019 and mechanical circulatory support devices: A comprehensive review
by: Kevin John, et al.
Published: (2022-09-01)

Severe Clozapine Poisoning Treated by Extracorporeal Blood Purification Therapy
by: Andreas Hartjes, et al.
Published: (2023-07-01)

How small is enough for the left heart decompression cannula during extracorporeal membrane oxygenation?
by: Sua Kim, et al.
Published: (2019-11-01)

Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study
by: Toru Kondo, et al.
Published: (2022-02-01)

Preliminary report of extracorporeal blood purification therapy in patients receiving LVAD: Cytosorb or Jafron HA330
by: Nurmykhametova Zhuldyz, et al.
Published: (2024-03-01)

Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
by: Asieb Sekandarzad, et al.
Published: (2022-03-01)

Comparing CABG and PCI across the globe based on current regional registry evidence
by: Tulio Caldonazo, et al.
Published: (2022-12-01)

Extracorporeal Left Ventricular Assist Device as a Bridge to Surgery for Ventricular Septal Rupture After Acute Myocardial Infarction
by: Tong L, et al.
Published: (2023-11-01)

CytoSorb<sup>®</sup> Hemadsorption in Cardiogenic Shock: A Real-World Analysis of Hemodynamics, Organ Function, and Clinical Outcomes During Mechanical Circulatory Support
by: Julian Kreutz, et al.
Published: (2025-01-01)

Early left ventricular unloading after extracorporeal membrane oxygenation: rationale and design of EARLY‐UNLOAD trial
by: Min Chul Kim, et al.
Published: (2023-08-01)

Cytosorb use in postoperative treatment of a patient with infective endocarditis
by: Marković Dejan, et al.
Published: (2018-01-01)

Efficacy of hemoadsorption in the severe course of COVID-19
by: Aleksei Yurievitch Yakovlev, et al.
Published: (2025-03-01)